ERBB2 and breast cancer: A high frequency of TILs has been observed in the more aggressive breast cancer subtypes, including the ER subtypes, that is, HER2 and basal, highly inflamed tumors, and the highly proliferating luminal B subtype, but are low in the less aggressive luminal A subtype.